Loading clinical trials...

Microvesicle Production After Acute Trauma and Its Clinical Impact on Venothromboembolism | Clinical Trials | Clareo Health

COMPLETED

Microvesicle Production After Acute Trauma and Its Clinical Impact on Venothromboembolism

NCT01264458•Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this research study is to look at how trauma affects the ability of blood to clot. The blood of people who suffer a traumatic injury can under-clot or over-clot, and this research study will look at blood drawn from people after they suffer a traumatic injury to see how well their blood clots.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Male and female patients 18 years of age or older
•Blunt trauma patients including those with closed head injury
•Penetrating trauma patients

Exclusion Criteria

•Are on therapeutic anticoagulation
•Have preexisting coagulopathy
•Patients greater than 12 hours from time of injury
•Have history of malignancy or preexisting diagnosis of sepsis or renal failure
•Patients with burn injuries
•Male and female patients younger than 18 years of age
•Pregnant patients

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Key Dates

Start Date

January 1, 2011

Primary Completion Date

December 14, 2014

Completion Date

December 14, 2014

Last Updated

April 8, 2021

Enrollment

1,234

ACTUAL participants

Conditions

Venothromboembolism

AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.

NCT06939803

Venothromboembolism

View study

COMPLETED

Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism

NCT01107327

Venothromboembolism

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 8, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions